A case is presented of a 10-year-old girl with refractory leukemia with poor prognosis and chemotherapy-induced heart failure. She is evaluated for a ventricular assist device (VAD), but the pediatric heart failure team views VAD as clinically inappropriate due to her active oncologic problems. This article examines ethical concerns that arise in deciding whether to offer and use this technology.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/amajethics.2019.380 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!